13D Filing: Bain Capital Life Sciences Fund, L.P. and Dicerna Pharmaceuticals Inc (DRNA)

Page 3 of 5 – SEC Filing


CUSIP No. 253031108 13D/A Page 3 of 5
  1 

Names of
Reporting Persons

BCIP Life Sciences Associates, LP

  2

Check the Appropriate Box if a Member
of a Group

(a)  ☐        (b)  ☐

  3

SEC Use Only

  4

Source of Funds

WC

  5

Check if Disclosure of Legal
Proceedings is Required Pursuant to Item 2(d) or 2(e)

  6

Citizenship or Place of
Organization

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

  7 

Sole Voting Power

787,100 shares of Common Stock

  8

Shared Voting Power

0 shares of Common Stock

  9

Sole Dispositive Power

787,100 shares of Common Stock

10

Shared Dispositive Power

0 shares of Common Stock

11

Aggregate Amount Beneficially Owned by Each Reporting Person

787,100 shares of Common Stock

12

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares

13

Percent of Class Represented by Amount
in Row (11)

3.6%

14

Type of Reporting Person

PN

Follow Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)